Aclarion, Inc. (ACON) PT Raised to $22 at Ascendiant Capital

Ascendiant Capital analyst Lucas Ward raised the price target on Aclarion, Inc. (NASDAQ: ACON) to $22.00 (from $20.00) while maintaining a Buy rating.

The analyst comments "Adjusting 12-month price target to $22.00 (from $20.00): We are raising our 12- month target to $22.00, based on a NPV analysis. Our new target of $22.00 represents 1.9x upside from the current share price. With net cash per share of over $23 and a relatively modest cash burn of around $1.5 million per quarter, we believe downside is limited, while accelerating penetration of Aclarion’s 9-figure market opportunity with providers and payers provides ample upside opportunity. Risks to our thesis include slower than expected traction with payers and higher than expected marketing and administrative expenses."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• AI/ML Innovations plans $2M private placement on the CSE
• Boeing lands two U.S. defense contracts worth over $711M